Position in MGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,274,903
-$175,798 QoQ
Shares Held
441,143
-51.0% QoQ
Ownership
0.694%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $705,903,019 across 86 Biotechnology names. MGNX ranks #42 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
214,160 | $165,468,582 | |
| 2 | INCY |
Incyte Corp
|
1,717,978 | $161,696,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
212,204 | $70,211,937 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
789,429 | $51,020,796 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,431,071 | $29,980,937 | |
| 6 | EXEL |
Exelixis, Inc.
|
425,982 | $18,270,367 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,097,189 | $16,260,340 | |
| 8 | ARVN |
Arvinas, Inc.
|
1,441,521 | $15,280,122 |
All Filings in MGNX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,274,903 | 441,143 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,450,701 | 901,057 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,370,653 | 815,865 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,215,805 | 1,004,798 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $844,995 | 665,351 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,839,188 | 565,904 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,863,219 | 566,328 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,780,282 | 418,890 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,178,824 | 148,018 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,106,097 | 114,979 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,861,595 | 399,484 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $2,166,675 | 404,986 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,180,554 | 304,122 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $373,988 | 55,736 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $210,110 | 71,224 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,482,053 | 168,224 | Shares | Sole | 2022-05-16 | |
| 2020-09-30 | $465,611 | 18,484 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,880,957 | 210,636 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,294,629 | 222,445 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||